Skip to main content
. 2021 Oct 10;21:362. doi: 10.1186/s12893-021-01361-6

Table 1.

Patients and disease characteristics

LTGN (n = 21) LATLSN (n = 32) P value
Age (years) 56 (21–84) 57 (20–79) 0.63
Male, n 11 18 0.78
Etiology of pancreatitis, n 0.08
Gallstones 8 15
Hypertriglyceridemia 4 7
Alcohol abuse 3 4
Idiopathic and others 6 6
Organ dysfunction, n 0.84
Renal 4 7
Lung 3 6
Cardiovascular 3 3
Multiple 2 3
ASA scores, n 0.96
 III 11 17
 IV 10 15
Charlson index of comorbidities 2 (0–7) 2 (0–8) 0.87
APACHE II socre, n 0.79
 0–8 3 3
 8–16 14 24
 > 16 4 5
CT severe index, n 0.92
 0–6 5 8
 7–10 16 24
Pancreatic necrosis, n 0.70
 < 30% 2 2
 30–50% 6 6
 > 50% 13 23
Inflammatory markers on operation time
White cell count (× 109/L) 12.3 (2.9–32.6) 13.2 (4.8–27.5) 0.62
C-reactive protein (mg/L) 156 (17.9–348) 148 (6.97–412) 0.30
Procalcitonin (ng/ml) 1.02 (0.07–100) 0.95 (0.09–74.8) 0.28
Maximum length of necrotic collection (cm) 9.3 (5.0–18.2) 8.6 (6.1–15.5) 0.39
Infected necrosis, n 19 29 1.00
Tertiary referral, n 16 25 0.87
Time to intervention from onset of pancreatitis (days) 37 (25–119) 35 (29–372) 0.69
Site of thrombus, n 0.59
 Splenic vein 14 19
 Portal-splenic vein 7 13